Garcia-Beltran WF, 2022, Cell |
mRNA-based COVID-19 vaccine boosters induce neutralizing immunity against SARS-CoV-2 Omicron variant |
210 |
210.00 |
70.96 |
Andrews N, 2022, New Engl J Med |
COVID-19 Vaccine Effectiveness against the Omicron (B.1.1.529) Variant |
165 |
165.00 |
55.75 |
Hoffmann M, 2022, Cell |
The Omicron variant is highly resistant against antibody-mediated neutralization: Implications for control of the COVID-19 pandemic |
160 |
160.00 |
54.06 |
Wolter N, 2022, Lancet |
Early assessment of the clinical severity of the SARS-CoV-2 omicron variant in South Africa: a data linkage study |
145 |
145.00 |
48.99 |
Dejnirattisai W, 2022, Cell |
SARS-CoV-2 Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses |
137 |
137.00 |
46.29 |
Vanblargan La, 2022, Nat Med |
An infectious SARS-CoV-2 B.1.1.529 Omicron virus escapes neutralization by therapeutic monoclonal antibodies |
124 |
124.00 |
41.90 |
Torjesen I, 2021, BMJ |
SARS-CoV-2 Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses |
88 |
44.00 |
4.98 |
Kumar S, 2022, J Med Virol |
An infectious SARS-CoV-2 B.1.1.529 Omicron virus escapes neutralization by therapeutic monoclonal antibodies |
87 |
87.00 |
29.40 |
Accorsi EK, 2022, JAMA |
COVID-19: Omicron may be more transmissible than other variants and partly resistant to existing vaccines, scientists fear |
87 |
87.00 |
29.40 |
Tarke A, 2022, Cell |
SARS-CoV-2 vaccination induces immunological T cell memory able to cross-recognize variants from Alpha to Omicron |
85 |
85.00 |
28.72 |